LLY
Price:
$795.67
Market Cap:
$755.34B
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various he...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1972-06-01
Stock Exchange
NYSE
Ticker
LLY
According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current ROE is 65.15%. This represents a change of 291.75% compared to the average of 16.63% of the last 4 quarters.
The mean historical ROE of Eli Lilly and Company over the last ten years is 53.99%. The current 65.15% ROE has changed 20.68% with respect to the historical average. Over the past ten years (40 quarters), LLY's ROE was at its highest in in the March 2019 quarter at 171.01%. The ROE was at its lowest in in the December 2017 quarter at -14.29%.
Average
53.99%
Median
40.77%
Minimum
-1.76%
Maximum
177.91%
Discovering the peaks and valleys of Eli Lilly and Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 441.03%
Maximum Annual ROE = 177.91%
Minimum Annual Increase = -1967.66%
Minimum Annual ROE = -1.76%
Year | ROE | Change |
---|---|---|
2023 | 48.65% | -17.03% |
2022 | 58.64% | -5.67% |
2021 | 62.16% | -43.38% |
2020 | 109.79% | -38.29% |
2019 | 177.91% | 441.03% |
2018 | 32.88% | -1967.66% |
2017 | -1.76% | -109.01% |
2016 | 19.54% | 18.24% |
2015 | 16.53% | 6.29% |
2014 | 15.55% | -41.48% |
The current ROE of Eli Lilly and Company (LLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
56.48%
5-year avg
91.43%
10-year avg
53.99%
Eli Lilly and Company’s ROE is less than Johnson & Johnson (20.94%), greater than Bristol-Myers Squibb Company (-36.26%), less than AbbVie Inc. (65.72%), less than Pfizer Inc. (4.72%), less than Merck & Co., Inc. (29.27%), less than Amgen Inc. (68.49%), less than Gilead Sciences, Inc. (0.65%),
Company | ROE | Market cap |
---|---|---|
20.94% | $351.15B | |
-36.26% | $117.15B | |
65.72% | $317.73B | |
4.72% | $151.34B | |
29.27% | $251.57B | |
68.49% | $142.17B | |
0.65% | $117.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Eli Lilly and Company's ROE?
How is the ROE calculated for Eli Lilly and Company (LLY)?
What is the highest ROE for Eli Lilly and Company (LLY)?
What is the 3-year average ROE for Eli Lilly and Company (LLY)?
What is the 5-year average ROE for Eli Lilly and Company (LLY)?
How does the current ROE for Eli Lilly and Company (LLY) compare to its historical average?